NAV
$34.85
AUM
$37.1M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.80
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +9.60% | +12.64% | +16.93% | +30.46% | +17.18% | - |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Co | 21.35% |
| 2 | ASND | Ascendis Pharma AS | 14.71% |
| 3 | LEGN | Legend Biotech Corp ADR | 4.95% |
| 4 | ISRG | Intuitive Surgical Inc | 4.05% |
| 5 | ABBV | AbbVie Inc | 4.03% |
| 6 | ABVX | Abivax SA ADR | 3.85% |
| 7 | RYTM | Rhythm Pharmaceuticals Inc | 3.73% |
| 8 | INSM | Insmed Inc | 3.18% |
| 9 | GILD | Gilead Sciences Inc | 2.79% |
| 10 | BSX | Boston Scientific Corp | 2.59% |
The fund invests primarily in equity securities, principally common and preferred stocks of companies of any market capitalization. Under normal market conditions, the fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry (“health care companies”). It is non-diversified.
Inception Date: 2022-11-16